PrimeRFP SCOUT · Federal Contract Recompete Brief

12905B22F0045SEQUEL II sequencing KIT 2.0 SMRT — Pacific Biosciences of California, Inc

Pacific Biosciences of California, Inc holds $7.8M across 81 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 12405B21D0002. PoP ended Jun 13, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Usda Ars Pwa Aao Acq/Per Prop

Awarding office

Pacific Biosciences of California, Inc

Recipient

Jun 13, 2022

PoP end

$105K

Obligated

$105K

Potential

334516

NAICS

6640

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pacific Biosciences of California, Inc — $90

Contract facts

Federal

Contract number12905B22F0045

Also listed as12905B-22-F-0045

Also listed as12405B21D0002-12905B22F0045

AgencyUsda Ars Pwa Aao Acq/Per Prop

Awarding officeUsda Ars Pwa Aao Acq/Per Prop

Awarding agencyDepartment of Agriculture (USDA)

Funding agencyDepartment of Agriculture (USDA)

IncumbentPacific Biosciences of California, Inc

CAGE49H66

UEICP22V46XYQK6

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6640

Parent IDIQ / IDV12405B21D0002

Place of performanceMENLO PARK CA

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startApr 14, 2022

PoP end (current)Jun 13, 2022

Obligated$105K

Current value$105K

Potential value$105K

SEQUEL II SEQUENCING KIT 2.0 & SMRT CELL 8M TRAY is a federal award for Usda Ars Pwa Aao Acq/Per Prop held by Pacific Biosciences of California, Inc. Estimated value $105K ($105K obligated). Current period of performance ends Jun 13, 2022. Place of performance: MENLO PARK CA.

SEQUEL II SEQUENCING KIT 2.0 & SMRT CELL 8M TRAY

Recompete timing

Public

● Past PoP end (1550 days ago)

Current PoP ended Jun 13, 2022 (1550 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Pacific Biosciences of California, Inc — $7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($7.8M) · all agencies

Department of Health and Human Services (HHS)$5.3M · 68%Department of Agriculture (USDA)$2.3M · 29%Department of Defense (DOD)$197K · 3%

Open full company profile →

Related awards

Same parent · incumbent

75N92025P00381

REVIO SMRT CELLS AND SEQUENCING REAGENTS - NEW AWARD

$198K

Sep 26, 2026

1232SA26F0221

LONG-READ SEQUENCING REAGENTS OF WHOLE GENOME ANALYSES

$240K

Sep 30, 2026

1232SA25F0277

PACBIO REAGENT KITS. ALL REAGENTS FOR SEQUENCING 24 REVIO SMRT CELLS QUANTITY 8, AND ASSOC…

$233K

Sep 30, 2026

75F40121P00562

VERSATILE SEQUENCING II SYSTEM

$483K

Nov 16, 2026

75N98026P00928

NHGRI: SUPPLY: SEQUENCING REAGENTS: N/A

$347K

Jul 7, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 12905B22F0045?

12905B22F0045 (SEQUEL II sequencing KIT 2.0 SMRT) is a Usda Ars Pwa Aao Acq/Per Prop award with a potential value of $105K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 12905B-22-F-0045?

12905B-22-F-0045 is the dashed form of PIID 12905B22F0045 (SEQUEL II sequencing KIT 2.0 SMRT), held by Pacific Biosciences of California, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 12905B22F0045?

Usda Ars Pwa Aao Acq/Per Prop awarded 12905B22F0045 to Pacific Biosciences of California, Inc (potential $105K).

Who is the incumbent on 12905B22F0045?

Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Jun 13, 2022.

When does Pacific Biosciences of California, Inc’s 12905B22F0045 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 13, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 12905B22F0045 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Apr 14, 2022